Flomoxef Sodium

氟氧头孢钠

Report date: 2022/05/18 17:41:36
NME

Base Information

Drug NameFlomoxef Sodium
Drug Alias NameFlomoxefum氟莫头孢钠氟氧头孢EfmoxFlumarin +[8] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibioticsSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsUrinary Tract InfectionsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryJapan
Original Approved Date1988/01/01
Country/TerritoryRussian FederationMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShionogi & Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShionogi & Co Ltd
Inactive CompaniesTakeda Pharmaceutical Co Ltd
Active IndicationsBacterial Infections
Inactive IndicationsUrinary Tract Infections

Other Information

ATC CodeJ01DC14
Related LinksWikipediaKEGG